semaglutide and heart failure in Patients with Obesity-Related Type 2 Diabetes | NEJM Impact of Semaglutide 2.4 mg

In absolute terms, that was ~15 kg weight loss on semaglutide vs ~2.5 kg on placebo an unprecedented result for a medication ( [12] )

Why is it important to start GLP-1 medications with a gradual dose increase, and how does this improve safety and effectiveness

Papillary thyroid cancer was the most common thyroid cancer subtype, followed by follicular, medullary, and other types

10 The mechanisms of action as they relate to weight loss are understood to stem from paracrine and endocrine signalling pathways within the GI tract, pancreas, and central nervous system that delay gastric emptying, decrease appetite, augment pancreatic beta-cell insulin secretion, and suppress pancreatic glucagon release